Phase III
Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases – Nature Nanotechnology
Source Node: 3088797
Time Stamp: Jan 28, 2024
QuSecure says U.S government agencies are moving faster on PQC – Inside Quantum Technology
Source Node: 3084766
Time Stamp: Jan 26, 2024
Eisai Submits New Drug Application for Mecobalamin Ultrahigh-Dose Formulation in Japan for the Indication of Amyotrophic Lateral Sclerosis
Source Node: 3086330
Time Stamp: Jan 26, 2024
CBDCs, Green Finance Among BIS Innovation Hub Projects Announced for 2024 – Fintech Singapore
Source Node: 3081613
Time Stamp: Jan 24, 2024
IP Scholarship, Citations, and Knowledge Governance: Some Insights from the History of IP Teaching in India
Source Node: 3075270
Time Stamp: Jan 20, 2024
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
Source Node: 3060839
Time Stamp: Jan 12, 2024
Sweden Signs Agreement To Train Combat Pilots In Italy For The Next Decade
Source Node: 3004280
Time Stamp: Dec 8, 2023
Buy a Lottery Ticket or Invest in a Psychedelics Company? – It’s Long Odds Trying to Pick a Winner in Psychedelic Stocks
Source Node: 2982958
Time Stamp: Nov 26, 2023
Proton therapy on an upward trajectory while FLASH treatment schemes get ready to shine – Physics World
Source Node: 2953282
Time Stamp: Oct 24, 2023
Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics – Nature Nanotechnology
Source Node: 2887618
Time Stamp: Sep 17, 2023
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results
Source Node: 2843511
Time Stamp: Aug 25, 2023
Delcath Gets FDA Approval for Cancer Drug-Device Combo 10 Years After Rejection | BioSpace
Source Node: 2827179
Time Stamp: Aug 15, 2023
Disaster Risk Reduction and Open Data Newsletter: August 2023 Edition – CODATA, The Committee on Data for Science and Technology
Source Node: 2801194
Time Stamp: Aug 1, 2023